Back

Prognostic value of a thyroid–endothelial phenotype in HFpEF: a large-scale interpretable machine learning cohort study revealing biological dissociation

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: HFpEF: challenges in diagnostics and treatment Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jiaying Yang

Beijing (China)

6 More presentations in this session

Presentation thumbnail
Recovered versus preserved ejection fraction in heart failure: long-term outcomes and the role of sustained remission
Doctor E. Tartaglia (Modena, IT)
Abstract
Presentation thumbnail
Unrecognized heart failure with preserved ejection fraction in COPD: phenotyp-ing a prospective cohort using the HFA-PEFF score
Doctor L. Duus (Copenhagen, DK)
Abstract
Presentation thumbnail
Treatment adherence and risk prediction in HFpEF: a machine learning and structural equation modeling study
Doctor Q. Su (Lanzhou, CN)
Abstract
Presentation thumbnail
Metabolomics integrated with transcriptomics analysis: identifying biomarkers for 4-year all-cause mortality in heart failure patients with preserved ejection fraction in the Chinese Han population
Miss Y. Li (CN)
Abstract
Presentation thumbnail
Prognostic impact of the HFA-PEFF and H2FPEF scores in patients with sick sinus syndrome
Doctor S. Mishima (Kamogawa, JP)
Abstract

Access the full session

Session thumbnail
HFpEF: challenges in diagnostics and treatment

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Integration of echocardiographic and biomarker parameters for functional stratification and risk prediction in HFpEF patients
13 December 2025
thumbnail
Congress Presentation
Thyroid function and outcomes in heart failure with mildly reduced ejection fraction: insights from a large, retrospective registry
1 September 2025
thumbnail
Congress Presentation
Deep learning for mortality prediction in patients with a de-novo or worsened heart failure
29 August 2021
thumbnail
Congress Presentation
Exploring phenotypes in hypertrophic cardiomyopathy with machine learning data integration. A multicentric, multimodality pilot study.
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources